| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/09/2013 | CN103347882A Substituted n-(1h-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type iii receptor tyrosine kinase inhibitors |
| 10/09/2013 | CN103347874A Dimeric iap inhibitors |
| 10/09/2013 | CN103347860A Nampt抑制剂 Nampt inhibitor |
| 10/09/2013 | CN103347859A Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives |
| 10/09/2013 | CN103347849A Homo- and hetero-polyamino-acid derivatives of fullerene C60, method for producing same, and pharmaceutical composition based on said derivative |
| 10/09/2013 | CN103347848A Hydrated n-fullerene amino acids, method for producing the latter, and pharmaceutical compositions on the basis thereof |
| 10/09/2013 | CN103347521A Methods of metabolic targeting cancer cells using che mo- and immunotherapy for treating cancer |
| 10/09/2013 | CN103347520A Inhibitor of late SV40 factor (LSF) as cancer chemotherapeutics |
| 10/09/2013 | CN103347514A FGFR1 extracellular domain combination therapies |
| 10/09/2013 | CN103347511A Potentiator of antitumor activity of chemotherapeutic agent |
| 10/09/2013 | CN103347509A Compound and composition for treatment of cancer |
| 10/09/2013 | CN103347498A Pharmaceutical formulation for histone deacetylase inhibitors |
| 10/09/2013 | CN103343141A Restructured newcastle disease virus/genome plasmid for expressing humanized chimeric antibody cHAb18 and application thereof in anti-tumor treatment |
| 10/09/2013 | CN103343128A Aptamer LXL-3 for breast cancer cell MDA-MB-231 and applications of aptamer |
| 10/09/2013 | CN103343127A Aptamer LXL-2 for breast cancer cell MDA-MB-231 and applications of aptamer |
| 10/09/2013 | CN103343125A shRNA for inhibiting colon cancer cell PRPS2 expression, construction method of vector of shRNA, and use of shRNA |
| 10/09/2013 | CN103342757A Amphipathic chondroitin sulfate derivative and preparation method and application thereof |
| 10/09/2013 | CN103342751A Antibody neutralizers of human granulocyte macrophage colony stimulating factor |
| 10/09/2013 | CN103342735A Tumor specific target polypeptide and application thereof |
| 10/09/2013 | CN103342728A Compound for preventing cancers and preparation method thereof |
| 10/09/2013 | CN103342687A Compounds with tyrosinase inhibitory activity and preparation and application thereof |
| 10/09/2013 | CN103342665A Compounds having histone deacetylase inhibition activity and preparation method thereof |
| 10/09/2013 | CN103341186A Tumor-targeted radioactive nano-particles and preparation method thereof |
| 10/09/2013 | CN103341178A Pyridoxal phosphate functionalized calcium phosphate nano-particles, as well as preparation method and application thereof |
| 10/09/2013 | CN103341177A Reduction sensitive type polyethylene glycol-medicament conjugate and preparation method thereof |
| 10/09/2013 | CN103341168A Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or Flt1 antagonist for treating cancer |
| 10/09/2013 | CN103341166A Erlotinib-phthalocyanine conjugate as molecule-targeting anticancer photosensitizer |
| 10/09/2013 | CN103341165A Fe@Fe3O4 nanoparticles having photothermal function, and preparation method and application thereof |
| 10/09/2013 | CN103341159A Application of immune regulation markers TIPE2 (Tumor Necrosis Factor-a Induced Protein 8 like 2) in preparation of medicine used for treating vascular proliferation diseases |
| 10/09/2013 | CN103341157A Application of pingyangmycin combined sodium hyaluronate in medicine for treating venous malformation |
| 10/09/2013 | CN103341137A Formula and preparation method of traditional Chinese medicine for treating cancers |
| 10/09/2013 | CN103341130A Traditional Chinese medicine for treating breast disease and preparation method thereof |
| 10/09/2013 | CN103341110A Natural drug extract and preparation method thereof |
| 10/09/2013 | CN103341109A Natural drug extract and preparation method thereof |
| 10/09/2013 | CN103341030A Traditional Chinese medicine composition for treating leukemia |
| 10/09/2013 | CN103341012A Chinese medicine composition |
| 10/09/2013 | CN103340994A Natural medicine composition, preparation method and application thereof |
| 10/09/2013 | CN103340993A Natural medicinal composition |
| 10/09/2013 | CN103340971A Natural drug extract |
| 10/09/2013 | CN103340970A 中药组合物 Chinese medicine composition |
| 10/09/2013 | CN103340968A Natural medicine composition and preparation method thereof |
| 10/09/2013 | CN103340962A Natural pharmaceutical composition, and preparation method and application thereof |
| 10/09/2013 | CN103340955A Chinese medicine composition as well as preparation method and application thereof |
| 10/09/2013 | CN103340947A Natural medicine composition and preparation method as well as application thereof |
| 10/09/2013 | CN103340937A Natural medicinal composition |
| 10/09/2013 | CN103340935A Chinese medicine composition and preparation method thereof |
| 10/09/2013 | CN103340934A Natural medicament composition |
| 10/09/2013 | CN103340929A Natural drug extract |
| 10/09/2013 | CN103340927A Natural pharmaceutical composition, and preparation method and application thereof |
| 10/09/2013 | CN103340926A 中药组合物及其制备方法 Chinese medicine composition and its preparation method |
| 10/09/2013 | CN103340925A Natural pharmaceutical composition, and preparation method and application thereof |
| 10/09/2013 | CN103340920A Preparation method and application of fructus podophylli total flavone with multidrug resistance reversing activity |
| 10/09/2013 | CN103340919A Lucid ganoderma refined powder compound soft capsule and preparation method thereof |
| 10/09/2013 | CN103340905A Anti-tumor bioactive substance and preparation method thereof |
| 10/09/2013 | CN103340903A Extraction method and application of tumor exosome vaccine |
| 10/09/2013 | CN103340899A Formulation of oral compositions comprising arsenic trioxide and methods of use thereof |
| 10/09/2013 | CN103340887A Application of Polyflavanostilbene A in preparation of medicine for treating breast cancer |
| 10/09/2013 | CN103340883A Ceramide-based combined medicine for treating tumor |
| 10/09/2013 | CN103340879A Medical application of 11-ketoandrostenedione and 11-ketotestosterone |
| 10/09/2013 | CN103340876A Application of Asperverin in preparation of drug for treating nasopharynx cancer |
| 10/09/2013 | CN103340871A Application of Myriberine A in preparation of drug for treating biliary duct cancer |
| 10/09/2013 | CN103340870A Application of andrographolide and 5-fluorouracil combined medicine in preparation of medicine for treating colon cancer |
| 10/09/2013 | CN103340849A Application of naringenin in preparing medicament for preventing and/or treating abdominal aortic aneurysm |
| 10/09/2013 | CN103340847A Medical application of ethane dimethane sulfonate (EDS) |
| 10/09/2013 | CN103340845A 药物组合物 The pharmaceutical composition of |
| 10/09/2013 | CN102698286B Supramolecule assembly of targeting-delivery anticancer adamplatin and preparation of supramolecule assembly |
| 10/09/2013 | CN102698268B Electrically conductive macromolecular nano-material and application of electrically conductive macromolecular nano-material |
| 10/09/2013 | CN102600427B Chinese medicinal composition for treating hyperplasia of mammary glands and breast cancer |
| 10/09/2013 | CN102526668B Ginger/white pepper composition for relieving vomiting due to cancer chemotherapy and enhancing effect of cancer chemotherapy and preparation method thereof |
| 10/09/2013 | CN102440961B Targeting polymer micelle containing acid-sensitive subsurface, and preparation method thereof |
| 10/09/2013 | CN102295635B Antitumor medicament tetralin amide compounds and pharmaceutically acceptable salts thereof as well as preparation method and application of antitumor medicament tetralin amide compounds |
| 10/09/2013 | CN102276444B Fatty acid compounds and preparation method and application thereof |
| 10/09/2013 | CN102234262B Method for preparing caffeic acid hydroxycoumarin ester compounds |
| 10/09/2013 | CN102061322B Method for preparing polysaccharide, flavone and dietary fiber of peanut hulls in united manner |
| 10/09/2013 | CN101830984B Double-targeted hybrid polypeptide for tumor diagnosis and treatment |
| 10/09/2013 | CN101724072B Sequence and application thereof of anti-tumor monoclonal antibody |
| 10/09/2013 | CN101374807B Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
| 10/08/2013 | US8552054 Anticancer agents, viricides, psychological disorders |
| 10/08/2013 | US8552040 Isoxazoline compounds having MIF antagonist activity |
| 10/08/2013 | US8552029 Quinoline derivatives and uses of the same |
| 10/08/2013 | US8552018 Substituted tricyclic compounds as protein kinase inhibitors |
| 10/08/2013 | US8552016 Anti-cancer cyclopenta(g)quinazoline compounds |
| 10/08/2013 | US8552014 Methods of using selective chemotherapeutic agents for targeting tumor cells |
| 10/08/2013 | US8552013 Heterocyclic compounds based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 10/08/2013 | US8551992 Aminooxazole inhibitors of cyclin dependent kinases |
| 10/08/2013 | US8551977 Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals |
| 10/08/2013 | US8551967 Formulations with anti-tumour action |
| 10/08/2013 | US8551951 Pharmaceutical preparations and methods for inhibiting tumors |
| 10/08/2013 | US8551936 Defensin-antigen fusion proteins |
| 10/08/2013 | US8551699 PCA3, PCA3 genes, and methods of use |
| 10/08/2013 | US8551490 Genetic products differentially expressed in tumors and use thereof |
| 10/08/2013 | US8551489 Methods for the treatment of cancers |
| 10/08/2013 | CA2725598C Antineoplastic combinations containing hki-272 and vinorelbine |
| 10/08/2013 | CA2682859C Crystalline forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl)indazole for treatment of abnormal cell growth in mammals |
| 10/08/2013 | CA2596178C Method for producing a drug extract that contains hydroxystilbene |
| 10/08/2013 | CA2596171C Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases |
| 10/08/2013 | CA2570321C Inhibitors of iap |
| 10/08/2013 | CA2542898C Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents |
| 10/08/2013 | CA2537135C Pyrimidothiophene compounds |
| 10/08/2013 | CA2536492C Process for producing cytotoxic lymphocytes |